BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 29905852)

  • 21. Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention.
    Aleksandrova K; Egea Rodrigues C; Floegel A; Ahrens W
    Curr Obes Rep; 2020 Sep; 9(3):219-230. PubMed ID: 32594318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis.
    Krochmal M; Cisek K; Filip S; Markoska K; Orange C; Zoidakis J; Gakiopoulou C; Spasovski G; Mischak H; Delles C; Vlahou A; Jankowski J
    Sci Rep; 2017 Aug; 7(1):9091. PubMed ID: 28831120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding osteoarthritis pathogenesis: a multiomics system-based approach.
    Ratneswaran A; Rockel JS; Kapoor M
    Curr Opin Rheumatol; 2020 Jan; 32(1):80-91. PubMed ID: 31724972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrative methods for analyzing big data in precision medicine.
    Gligorijević V; Malod-Dognin N; Pržulj N
    Proteomics; 2016 Mar; 16(5):741-58. PubMed ID: 26677817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 10. Role of high dimensional technology in preeclampsia (omics in preeclampsia).
    Youssef L; Testa L; Crovetto F; Crispi F
    Best Pract Res Clin Obstet Gynaecol; 2024 Feb; 92():102427. PubMed ID: 37995432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive biomarkers for type 2 of diabetes mellitus: Bridging the gap between systems research and personalized medicine.
    Kraniotou C; Karadima V; Bellos G; Tsangaris GT
    J Proteomics; 2018 Sep; 188():59-62. PubMed ID: 29518575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-cell omics in ageing: a young and growing field.
    He X; Memczak S; Qu J; Belmonte JCI; Liu GH
    Nat Metab; 2020 Apr; 2(4):293-302. PubMed ID: 32694606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
    Del Boccio P; Rossi C; di Ioia M; Cicalini I; Sacchetta P; Pieragostino D
    Proteomics Clin Appl; 2016 Apr; 10(4):470-84. PubMed ID: 27061322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
    Pecak M; Korošec P; Kunej T
    OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unveiling the future of metabolic medicine: omics technologies driving personalized solutions for precision treatment of metabolic disorders.
    Singh S; Sarma DK; Verma V; Nagpal R; Kumar M
    Biochem Biophys Res Commun; 2023 Nov; 682():1-20. PubMed ID: 37788525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Holistic Integration of Omics Tools for Precision Nutrition in Health and Disease.
    Ramos-Lopez O; Martinez JA; Milagro FI
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
    Tebani A; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 404-error "Disease not found": Unleashing the translational potential of -omics approaches beyond traditional disease classification in heart failure research.
    Esquivel Gaytan A; Bomer N; Grote Beverborg N; van der Meer P
    Eur J Heart Fail; 2024 Jun; 26(6):1313-1323. PubMed ID: 38741225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From flesh to bones: Multi-omics approaches in forensic science.
    Procopio N; Bonicelli A
    Proteomics; 2024 Jun; 24(12-13):e2200335. PubMed ID: 38683823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Application of Omics Technologies in the Research of Neurotoxicology.
    Shao W; Li H
    Methods Mol Biol; 2021; 2326():143-154. PubMed ID: 34097266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advancing neuro-oncology of glial tumors from big data and multidisciplinary studies.
    Lin CA; Berger MS
    J Neurooncol; 2020 Jan; 146(1):1-7. PubMed ID: 31853838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.
    Judes G; Rifaï K; Daures M; Dubois L; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
    Cancer Lett; 2016 Nov; 382(1):77-85. PubMed ID: 26965997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer.
    Matsuoka T; Yashiro M
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease.
    Cisek K; Krochmal M; Klein J; Mischak H
    Nephrol Dial Transplant; 2016 Dec; 31(12):2003-2011. PubMed ID: 26487673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The systems medicine of neonatal abstinence syndrome.
    Stone WL; Wood DL; Justice NA; Shah DS; Olsen ME; Bharti D
    Front Biosci (Landmark Ed); 2020 Jan; 25(4):736-759. PubMed ID: 31585915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.